BIOMARKER FOR ASSESSING RESPONSE TO CHYMASE TREATMENT
    4.
    发明申请
    BIOMARKER FOR ASSESSING RESPONSE TO CHYMASE TREATMENT 审中-公开
    生物标记评估对CHYMASE治疗的反应

    公开(公告)号:US20100003712A1

    公开(公告)日:2010-01-07

    申请号:US12474413

    申请日:2009-05-29

    IPC分类号: C12Q1/02 C07K14/715

    摘要: A biomarker that correlates to treatment with drugs that inhibit chymase is disclosed. This biomarker has been shown to have utility in assessing response to chymase inhibitor compounds. The immunoreactivity or levels of the biomarker is increased upon treatment with chymase inhibitor compounds, thus indicating that this biomarker is involved in chymase activity.

    摘要翻译: 公开了与用抑制胃促胰酶的药物治疗相关的生物标志物。 该生物标志物已被证明可用于评估对胃促胰酶抑制剂化合物的反应。 在用糜酶抑制剂化合物治疗时,生物标志物的免疫反应性或水平增加,因此表明该生物标志物参与糜酶活性。

    Processing of SLPI by chymase
    5.
    发明申请
    Processing of SLPI by chymase 有权
    通过胃肠酶处理SLPI

    公开(公告)号:US20070166779A1

    公开(公告)日:2007-07-19

    申请号:US11652753

    申请日:2007-01-12

    IPC分类号: C12Q1/37

    CPC分类号: C12Q1/37 G01N2333/811

    摘要: It is now discovered that human chymase cleaves human SLPI at a specific site and that this cleavage can be used as an indicator of chymase activity. The present invention provides methods of diagnosing a chymase-associated disease or evaluating the efficiency of a treatment of a chymase-associated disease in a human subject by measuring SLPI processing, as well as other related methods and compositions.

    摘要翻译: 现在发现人糜酶在特定位点切割人SLPI,并且该切割可以用作糜酶活性的指示剂。 本发明提供了通过测量SLPI处理以及其它相关方法和组合物来诊断糜酶相关疾病或通过测量人受试者中糜酶相关疾病的治疗效率的方法。

    Human voltage gated sodium channel β1A subunit and methods of use
    8.
    发明授权
    Human voltage gated sodium channel β1A subunit and methods of use 有权
    人电压门控钠通道β1A亚基和使用方法

    公开(公告)号:US07408036B2

    公开(公告)日:2008-08-05

    申请号:US11370490

    申请日:2006-03-08

    IPC分类号: C07K14/705

    摘要: DNAs encoding human voltage gated sodium channel β1A subunit have been cloned and characterized. The recombinant protein is capable of forming biologically active protein. The cDNA's have been expressed in recombinant host cells that produce active recombinant protein. The recombinant protein is also purified from the recombinant host cells. In addition, the recombinant host cells are utilized to establish a method for identifying modulators of the receptor activity, and receptor modulators are identified.

    摘要翻译: 编码人电压门控钠通道β1A亚基的DNA已被克隆和表征。 重组蛋白能够形成生物活性蛋白。 cDNA已经在产生活性重组蛋白的重组宿主细胞中表达。 重组蛋白也从重组宿主细胞中纯化。 此外,重组宿主细胞用于建立识别受体活性调节剂的方法,并鉴定受体调节剂。